Ehrlichioses are recognized as important emerging tickborne diseases in humans and wild and domestic animals. The brown dog tick, *Rhipicephalus sanguineus*, is the main tick that infests dogs in Chile ([@R1]). This tick species is a vector of *Ehrlichia canis* and has been implicated, but not confirmed, as a vector of *Anaplasma platys* ([@R2]). Serologic and clinical evidence of canine ehrlichiosis and serologic evidence of human ehrlichiosis have been reported in Chile ([@R3]*,*[@R4]). The purpose of this study was to identify the etiologic agent of canine ehrlichiosis in Chile.

The Study
=========

Blood samples were obtained from 30 pet dogs seen in a private veterinary clinic in Santiago, Chile, with tick infestation and clinical signs compatible with ehrlichiosis (hemorrhagic manifestations and thrombocytopenia). We performed a nested PCR to amplify a portion of the 16S rRNA gene by using specific primers for the genus *Ehrlichia* and for *Ehrlichia* spp. DNA was extracted from 300 μL of whole blood by using the Wizard Genomic DNA Purification kit (Promega, Madison, WI, USA). For *Ehrlichia* genus--specific PCR, 2.5 μL of DNA was amplified by using outer primers EHR-OUT1 and EHR-OUT2 and inner primers GE2F and EHRL3-IP2 in 1 reaction with a final volume of 25 μL ([@R5]) ([Table 1](#T1){ref-type="table"}).

###### *Ehrlichia/Anaplasma* spp. PCR primers used in this study

  *Ehrlichia/Anaplasma* spp. (primer type)                                                                   Primer                               Primer sequence (5′→3′)           Region     Reference
  ---------------------------------------------------------------------------------------------------------- ------------------------------------ --------------------------------- ---------- ---------------
  *Ehrlichia* spp.,  *A. phagocytophilum*,  *E. canis*, *E. chaffeensis*,  *E. ewingii, A. platys* (outer)   EHR-OUT1                             CTGGCGGCAAGCCTAACACATGCCAACAT     16S rRNA   ([@R5])
  EHR-OUT2                                                                                                   GCTCGTTGCGGGACTTAACCCAACATCTCACGAC   16S rRNA                          ([@R5])    
  *Ehrlichia* spp. (inner)                                                                                   GE2F                                 GTTAGTGGCATACGGGTGAAT             16S rRNA   ([@R5])
  EHRL3-IP2                                                                                                  TCATCTAATAGCGATAAATC                 16S rRNA                          ([@R5])    
  *A. phagocytophilum* (inner)                                                                               ge9f                                 AACGGATTATTCTTTATAGCTTGCT         16S rRNA   ([@R6])
  ge2                                                                                                        GGCAGTATTAAAAGCAGCTCCAGG             16S rRNA                          ([@R6])    
  *E. canis*, *E. chaffeensis*,  *E. ewingii* (inner)                                                        HE3-R                                CTTCTATAGGTACCGTCATTATCTTCCCTAT   16S rRNA   ([@R5])
  *E. canis* (inner)                                                                                         *E. canis*                           CAATTATTTATAGCCTCTGGCTATAGGAA     16S rRNA   ([@R5])
  *E. chaffeensis* (inner)                                                                                   *E. chaffeensis*                     CAATTGCTTATAACCTTTTGGTTATAAATA    16S rRNA   ([@R5])
  *E. ewingii* (inner)                                                                                       *E. ewingii*                         CAATTCCTAAATAGTCTCTGACTATT        16S rRNA   ([@R5])
  *E. equi* (inner)                                                                                          *E. equi-3-IP2*                      GTCGAACGGATTATTCTTTATAGCTTG       16S rRNA   ([@R5])
  *E. platys* (inner)                                                                                        *EHRL3-IP2*                          TCATCTAATAGCGATAAATC              16S rRNA   ([@R5],[@R7])
  *E. platys*                                                                                                GATTTTTGTCGTAGCTTGCTA                16S rRNA                          ([@R7])    
  *E. platys* (outer)                                                                                        EEgro1F                              GAGTTCGACGGTAAGAAGTTCA            *groESL*   ([@R8])
  EEgro2R                                                                                                    CAGCGTCGTTCTTACTAGGAAC               *groESL*                          ([@R8])    
  *A. platys* (inner)                                                                                        SQ3F                                 ATTAGCAAGCCTTATGGGTC              *groESL*   ([@R9])
  SQ5F                                                                                                       TCAGTGTGTGAAGGAAGTTG                 *groESL*                          ([@R9])    
  SQ4R                                                                                                       CTTTAGGCTATCAAGAGATG                 *groESL*                          ([@R9])    
  SQ6R                                                                                                       TGCTTCCTATGTTCTTATCG                 *groESL*                          ([@R9])    

The first-round amplification included 20 cycles of denaturation at 94°C for 45 s, annealing at 72°C for 1.5 min, and chain extension at 72°C for 1.5 min. The second-round amplification included 50 cycles of denaturation at 94°C for 45 s, annealing at 50°C for 1 min, and chain extension at 72°C for 1 min, followed by a final extension at 72°C for 5 min. Amplification products were analyzed by agarose gel electrophoresis. The expected size of the amplification product was 120 bp. *A*. *phagocytophilum* DNA was used as a positive control (provided by Didier Raoult). For *Ehrlichia* spp.--specific amplification, we used the same set of outer primers for *Anaplasmataceae* and specific inner primers for *A*. *phagocytophilum* ([@R6]), *E*. *chaffeensis*, *E*. *ewingii*, and *E*. *canis* ([@R5]) ([Table 1](#T1){ref-type="table"}). For *A*. *platys* amplification, we used inner primers developed by Kordick et al. (EHRL3-IP2--*E. platys*) ([@R7]) ([Table 1](#T1){ref-type="table"}). Expected sizes of amplification products were 546, 395, 395, 389, and 151 bp, respectively.

The *Ehrlichia* genus PCR resulted in the expected DNA band in 6 of 30 dogs (dogs 7, 12, 17, 19, 23, and 25). These 6 samples were positive only for *A. platys*, showing the expected 151-bp product, and negative for other species tested ([Figure 1](#F1){ref-type="fig"}, panel A). *A*. *platys* PCR was also conducted on the remaining 24 *Ehrlichia*-negative samples; none were positive.

![A) *Anaplasma platys* nested PCR products of 30 blood samples from dogs in Chile. Positive samples from dogs 7, 12, 17, 19, 23, and 25 are indicated by a 150-bp band. --, PCR-negative control; dog 13, negative control; M, 50-bp DNA ladder. Value on the right is in basepairs. B) Second-round *A. platys groESL* nested PCR products of dog DNA samples with 3 sets of primers. Group A, SQ5F/SQ4R (790 bp); group B, SQ3F/SQ4R (1,170 bp); group C, SQ3F/SQ6R (360 bp). M, GeneRuler 1-kb DNA ladder (Fermentas, Hanover, MD, USA); Dog 13, negative control; --, PCR-negative control. Values on the left are in basepairs.](07-0021-F1){#F1}

DNA obtained from 3 16S rRNA PCR products (dogs 7, 17, and 25) was purified by using a commercial kit (Rapid Gel Extraction System; Marligen Biosciences, Ljamsville, Germany) and sequenced twice with an ABI 3100 genetic analyzer (Model 3100; Applied Biosystems, Foster City, CA, USA). The 16S rRNA sequences obtained were compared by using BLAST ([www.ncbi.nlm.nih.gov/blast](http://www.ncbi.nlm.nih.gov/blast)) with sequences available at GenBank. Sequences obtained were similar to that of *A*. *platys* strain Okinawa 1 (GenBank accession no. AF536828), with similarities of 98%, 95%, and 98%, respectively. GenBank accession nos. for 16S rRNA sequences of *A*. *platys* strains obtained in this study are DQ125260 and DQ125261, which correspond to strains from dogs 7 and 17, respectively.

For phylogenetic analysis, the *groESL* gene of *A*. *platys* was amplified from samples positive for *A*. *platys* 16S rRNA that had sufficient amounts of DNA (dogs 17, 23, and 25) and from 1 negative sample (dog 13). Reactions contained 2 μL of purified DNA as template in a total volume of 25 μL. Amplifications contained 1.25 U *Taq* DNA polymerase (Invitrogen, Carlsbad, CA, USA), 3 mmol/L MgCl~2~, 2.5 mmol/L deoxynucleotide triphosphates (Invitrogen), and 0.2 pmol/L of primers EEgro1F and EEgro2R ([@R8]) ([Table 1](#T1){ref-type="table"}). DNA was denatured by heating at 95°C for 10 min. PCR amplification included 40 cycles of denaturation at 95°C for 1.5 min, annealing at 52°C for 2 min, and extension at 72°C for 1.5 min, followed by a final extension at 72°C for 10 min. For nested amplifications, 1 μL of primary PCR products was used as the template in a total volume of 25 μL. Reaction conditions were the same as for primary amplifications. The primers used were SQ3F, SQ5F, SQ4R, and SQ6R ([@R9]) ([Table 1](#T1){ref-type="table"}). PCR products were analyzed by 1.5% agarose gel electrophoresis.

We amplified 3 overlapping fragments (790, 1,170, and 360 bp) in 3 16S rRNA--positive samples ([Figure 1](#F1){ref-type="fig"}, panel B). These DNAs were purified by using a commercial kit (Rapid Gel Extraction System; Marligen), sequenced, and analyzed for phylogenetic relationships. Multiple alignment analysis was performed with the ClustalW program ([www.ebi.ac.uk/clustalw](http://www.ebi.ac.uk/clustalw)). Calculation of distance matrices and construction of a phylogenetic tree were made with MEGA 3.1 software ([www.megasoftware.net](http://www.megasoftware.net)). A phylogenetic tree was constructed by the neighbor-joining method and distance matrices for the aligned sequences were calculated by using the Kimura 2-parameter method. Stability of the tree was estimated by bootstrap analysis of 1,000 replications. A final sequence of 686 bp obtained from the overlapping fragments was used for comparison and showed 100% identity between the 3 Chilean sequences and 99.8% similarity with sequences of the *A*. *platys groESL* gene deposited in GenBank ([Table 2](#T2){ref-type="table"}). Phylogenetic relationships of Chilean *A*. *platys* strains with other *Anaplasmataceae* species are shown in [Figure 2](#F2){ref-type="fig"}. GenBank accession no. for the *groESL* gene sequence of *A*. *platys* is EF201806 (corresponding to dogs 17, 23, and 25).

###### Nucleotide sequence differences among *groESL* genes from different strains of *Anaplasma platys*

  Strain                  Similarity,\* %   Nucleotide position†        
  ----------------------- ----------------- ---------------------- ---- ----
  591                     1259              1271                        
  *A. platys* Sommieres   100               G                      A    C
  *A. platys* Lara        100               --                     --   --
  *A. platys* RDC         100               --                     --   --
  *A. platys* Okinawa     100               --                     --   --
  *A. platys* Louisiana   99.7              --                     G    T
  Dog 17                  99.8              T                      --   --
  Dog 23                  99.8              T                      --   --
  Dog 25                  99.8              T                      --   --

\*Percentages of nucleotide sequence identities for 686-bp region determined from pairwise alignment. †Nucleotide positions of *A. platys* Sommieres strain, GenBank accession no. AY0441621. --, same base as the type strain.

![Phylogenetic relationship between 3 Chilean *Anaplasma platys* strains and other strains of the families *Rickettsiaceae* and *Anaplasmataceae* based on the *groESL* gene nucleotide sequences. GenBank accession nos. of *groESL* sequences used to construct the phylogenetic tree were the following: *A. platys* France Sommieres AY044161*; A. platys* Lara Venezuelan dog AF399916; *A. platys* from *Rhipicephalus sanguineus* ticks in the Democratic Republic of Congo AF478129; *A. platys* from a dog in Okinawa, Japan AY077621; *A. platys* from a dog in Louisiana, USA AY008300; *A. marginale* AF165812; *Ehrlichia equi* AF172162; *E. phagocytophyla* U96729*; E. chaffeensis* L10917; *E. canis* U96731; *E. muris* AF210459; *Ehrlichia* sp. from *Ixodes ovatus* AB032711; *E. ruminantium* U13638; *Neorickettsia risticii* U96732; *N. sennetsu* U88092; *Rickettsia prowazekii* Y15783; and *Bartonella henselae* U96734. Scale bar at the lower left indicates 0.05 substitutions per nucleotide.](07-0021-F2){#F2}

Conclusions
===========

We identified *A*. *platys* DNA in the blood of 6 dogs with clinical signs indicative of ehrlichiosis. These findings support the conclusion that *A*. *platys* is an etiologic agent of canine ehrlichiosis in Chile.

Since its first report in the United States in 1978 ([@R10]), *A*. *platys* has been described in several countries as the etiologic agent of cyclic thrombocytopenia in dogs. A tick vector of *A*. *platys* has not been determined, although *R*. *sanguineus* is the most suspected species ([@R2]). Because *R*. *sanguineus* is the only tick species that infests dogs in Santiago ([@R1]), our results support the conclusion that this species is the vector of *A*. *platys* in Chile.

A wide range of clinical manifestations of canine cyclic thrombocytopenia has been described. Cases from the United States have been described as mild or asymptomatic ([@R10]), and cases from Spain have more severe symptoms ([@R11]), which also seems to be the case in Chile. This variability in clinical symptoms of infection has not been clearly associated with strain variations ([@R11]--[@R13]).

Low diversity was observed when *groESL* gene sequences of Chilean strains were compared with other *A*. *platys* strains available in GenBank. This finding has also been observed in strains from different geographic origins ([@R13]). Recent studies have shown more genetic variability when sequences of the *gltA* gene were used ([@R11],[@R12]).

Evidence of the zoonotic potential of *A*. *platys* is scarce. In Venezuela, a few symptomatic human cases have been diagnosed since 1992 by the presence of platelet morulae in blood smears ([@R14]). Monocytic and platelet morulae were reported in a 17-month-old girl with fever and rash ([@R15]). However, none of these cases have been confirmed by molecular assays. Further studies that investigate the pathogenic and zoonotic role of *A*. *platys* should be conducted.
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